|
MTHFD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.924000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.679800E-01 |
| Normal-vs-Stage2 |
1.211960E-01 |
| Normal-vs-Stage3 |
6.781200E-03 |
| Normal-vs-Stage4 |
2.774000E-02 |
| Stage1-vs-Stage2 |
1.250820E-01 |
| Stage1-vs-Stage3 |
6.858400E-03 |
| Stage1-vs-Stage4 |
2.800400E-02 |
| Stage2-vs-Stage3 |
1.225580E-01 |
| Stage2-vs-Stage4 |
8.675800E-02 |
| Stage3-vs-Stage4 |
3.954600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.683600E-02 |
| Normal-vs-AfricanAmerican |
1.143020E-01 |
| Normal-vs-Asian |
2.126600E-01 |
| Caucasian-vs-AfricanAmerican |
5.328600E-01 |
| Caucasian-vs-Asian |
2.709600E-01 |
| AfricanAmerican-vs-Asian |
1.091950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.505600E-01 |
| Normal-vs-Female |
1.376700E-03 |
| Male-vs-Female |
3.445000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.872400E-02 |
| Normal-vs-Extreme_Weight |
7.950200E-01 |
| Normal-vs-Obese |
3.535600E-02 |
| Normal-vs-Extreme_Obese |
3.505700E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.286500E-02 |
| Normal_Weight-vs-Obese |
9.407200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.093950E-02 |
| Extreme_Weight-vs-Obese |
4.486300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.043980E-02 |
| Obese-vs-Extreme_Obese |
3.756100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.942170E-02 |
| Normal-vs-Age(41-60Yrs) |
8.535900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.280400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.542000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.951900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.498100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.111600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.338800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.937400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.345000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.421800E-02 |
| Normal-VS-Type2 PRCC |
1.323870E-03 |
| Normal-VS-KIRP CIMP |
5.78719999999588E-05 |
| Normal-VS-Unclassified PRCC |
8.889900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.28650000000385E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.21630000000395E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.719620E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.023990E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.747970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.85930000000157E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.232760E-01 |
| Normal-vs-N1 |
1.319830E-03 |
| Normal-vs-N2 |
2.230400E-01 |
| N0-vs-N1 |
3.696700E-03 |
| N0-vs-N2 |
2.687600E-01 |
| N1-vs-N2 |
9.257200E-01 |
|
|
